ALFA Finder| Metric | Q4 FY26 | Q3 FY26 | Q4 FY25 |
|---|---|---|---|
| Revenue from operations | 2.1 | 53.5 | 15.9 |
| Total income | 2.1 | 53.5 | 15.9 |
| Profit before exceptional items & tax | 0.2 | 1.4 | 0.7 |
| Profit before tax | 0.2 | 1.4 | 0.7 |
| Net profit | 0.2 | 1.0 | 0.5 |
| Operating margin | 9.5% | 2.6% | 4.4% |
A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.
| Net profit, year on year | -60.00% |
|---|---|
| Net profit, quarter on quarter | -80.00% |
| Revenue, year on year | -86.80% |
BSE results filing, BSE: 543594. Figures extracted from the filing.
Dipna Pharmachem Ltd: key numbers
- Share price
- ₹4.26
- Market cap
- ₹11.20 Cr
- Revenue (annual)
- ₹129.1 Cr
- Net profit (annual)
- ₹2.63 Cr
- P/E (TTM)
- 4.3×Sector 43.8×
- Promoter holding
- 9.13%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Dipna Pharmachem Ltd
All →Dipna Pharmachem Management Change
Dipna Pharmachem's board appointed two Additional Non-Executive Independent Directors and reconstituted the Audit, Nomination & Remuneration and Stakeholders Relationship Committees effective 3 November 2026. No capital, money, or business event is involved.
Dipna Pharmachem Board Meeting Date
Dipna Pharmachem's board meets on 4 November 2026 to consider unaudited results for the quarter ended 30 June 2026. The meeting has not yet been held.
Dipna Pharmachem Management Change
Dipna Pharmachem appointed Shyam Sundar Lohia as Company Secretary and Compliance Officer effective August 5, 2026. The board approved the appointment at its August 5 meeting.
Dipna Pharmachem Other Announcement
Dipna Pharmachem Ltd has filed its quarterly shareholding pattern for the period ending September 30, 2026, as required under SEBI regulations.
Dipna Pharmachem Other Announcement
Dipna Pharmachem Ltd has filed its quarterly shareholding pattern under Regulation 31(1)(b) of the SEBI LODR, detailing the distribution of equity shares.
Dipna Pharmachem Management Change
Dipna Pharmachem appointed two new Independent Directors effective May 11, 2026. Board committees were also reconstituted to enhance governance.